Document is current

Any future updates will be listed below

Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab

Crossref DOI link: https://doi.org/10.1186/s13075-015-0799-7

Published Online: 2015-10-09

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark